Addiction publishes press releases throughout the year. Please see the date-sorted list below.
Search Press Releases
2021 Press Releases
In a study of men in low and middle income countries, heavy drinking males were more likely to commit violence against their wives and girlfriends (intimate partner violence, or IPV) if they held sexist rather than egalitarian attitudes about women.
A new analysis of data from a randomised controlled trial of the stop-smoking drug varenicline (brand name Chantix in the US and Champix elsewhere), has provided clear evidence that varenicline does not increase the risk of psychiatric problems. The study also assessed the risk of psychiatric problems associated with bupropion and the nicotine patch. It similarly found moderate to strong evidence for no increased risk of neuropsychiatric adverse events relative to use of a placebo.
Ethnic minority groups may be missing out on a means of reducing smoking. A household survey in England has found it is less common for smokers of Asian, Arab, and other ethnicities to use e-cigarettes to try to reduce their cigarette consumption or when they are not allowed to smoke than those of White ethnicity.
2020 Press Releases
A study published in the scientific journal Addiction suggests that, contrary to what some are claiming, people in the US may not be substituting cannabis for opioids.
Two drug policy experts have identified gaps and challenges in New Zealand’s proposal for legalizing recreational cannabis. In advance of a widely-watched national referendum vote to be held this September, Associate Professor Chris Wilkins and Dr. Marta Rychert of Massey University argue in the pages of Addiction that New Zealand’s Cannabis Legislation and Control Bill (CLCB) needs to be strengthened in two critical areas.
A real-world study of over 600,000 adult participants without a history of depression has found that the stop-smoking medication varenicline does not appear to be associated with an increased risk of cardiovascular or neuropsychiatric hospitalization compared with nicotine replacement therapy (NRT).
The largest and most authoritative research trial of its kind testing the Allen Carr’s Easyway (ACE) method of quitting smoking has detected no difference in success rates between ACE and a specialist stop smoking service in the UK.
In Australia between 2007 and 2016, 81% to 85% of all cannabis was consumed by the 16% of all Australian cannabis users who used daily. Weekly users and daily users together accounted for an estimated 98% of all cannabis consumed in Australia between 2007 and 2016.
A new large study of Chinese adults has found that eight percent of men in China are problem drinkers, and that problem drinking is more prevalent among men of lower socio-economic status and in rural areas.
A 10-year study led by researchers at UCL of 41,610 smokers in England has found that smokers today show fewer signs of dependence than a decade ago but are less inclined to try to stop smoking.
2019 Press Releases
A new study published today by the scientific journal Addiction found a positive link between the number of people in England giving up smoking when using e-cigarettes to try and quit.
When the Department of Health (England) introduced financial incentives to encourage GPs to talk to patients about their drinking, there was a small, gradual increase in screening and the provision of alcohol advice. When the incentives stopped in 2015, rates of screening and advice-giving decreased immediately, and have stayed low ever since.
A new study found that raising the legal age of sale of cigarettes from 18 to 21 in the U.S. was associated with a 39% reduction in the odds of regular smoking in 18- to 20-year-olds who had experimented with cigarettes. The reduction was 50% in those with close friends who smoked at 16.
A new review of evidence from the UK has found high levels of alcohol dependence among hospital inpatients. The researchers estimate one in five patients in the UK hospital system uses alcohol harmfully, and one in ten is alcohol dependent.
Fetal Alcohol Spectrum Disorder (FASD) is 10 to 40 times higher in certain susceptible groups than the general population, including children in care, people in correctional services or special education services, Aboriginal populations, and people using specialized clinical services.